Cite
MLA Citation
G Mountzios et al.. “Position of an international panel of lung cancer experts on the decision for expansion of approval for pembrolizumab in advanced non-small-cell lung cancer with a PD-L1 expression level of ≥1% by the USA Food and Drug Administration.” Annals of oncology, vol. 30, 2019, pp. 1686–1688. http://access.bl.uk/ark:/81055/vdc_100099399045.0x00002c